Want to join the conversation?
$ZBRA said that macroeconomic uncertainty and a slow IT spending environment have continued to elongate the sales cycle in 2Q16. The company added that while some customers delayed their projects into future quarters, $ZBRA has not experienced any increase in order cancellations.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.